Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zeni

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|February 1, 1996
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled studyF Zeni, P Pain, M Vindimian, et al.
Intensive Care Medicine|August 3, 2000
Endotoxaemia in patients with severe sepsis or septic shockC Venet, F Zeni, A Viallon, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
Pathologie-Biologie|October 22, 2003
[Epidemic outbreaks control involving Staphylococcus aureus with reduced sensitivity to glycopeptides]F-O Mallaval, A Carricajo, I Martin, et al.
Critical Care Medicine|November 1, 1994
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study GroupJ F Dhainaut, A Tenaillon, Y Le Tulzo, et al.
Minerva Anestesiologica|February 27, 2014
Resistive Index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot studyD Schnell, M Reynaud, M Venot, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 20, 1999
ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumoniaF Zeni, C Parent, R Correa, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 8, 2018
Transfusion-associated hazards: A revisit of their presentationO Garraud, C Sut, A Haddad, et al.
Critical Care Medicine|January 6, 1999
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator GroupJ F Dhainaut, A Tenaillon, M Hemmer, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|February 1, 1996
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled studyF Zeni, P Pain, M Vindimian, et al.
Intensive Care Medicine|August 3, 2000
Endotoxaemia in patients with severe sepsis or septic shockC Venet, F Zeni, A Viallon, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
Pathologie-Biologie|October 22, 2003
[Epidemic outbreaks control involving Staphylococcus aureus with reduced sensitivity to glycopeptides]F-O Mallaval, A Carricajo, I Martin, et al.
Critical Care Medicine|November 1, 1994
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study GroupJ F Dhainaut, A Tenaillon, Y Le Tulzo, et al.
Minerva Anestesiologica|February 27, 2014
Resistive Index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot studyD Schnell, M Reynaud, M Venot, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 20, 1999
ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumoniaF Zeni, C Parent, R Correa, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 8, 2018
Transfusion-associated hazards: A revisit of their presentationO Garraud, C Sut, A Haddad, et al.
Critical Care Medicine|January 6, 1999
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator GroupJ F Dhainaut, A Tenaillon, M Hemmer, et al.
Pageof 6